NBC NewsPfizer, BioNTech ask FDA for full approval of Covid-19 vaccineMay 7, 2021Erika Edwards & Akshay SyalBy Erika Edwards & Akshay Syalbookmark_bordersharemore_vert
National GeographicWhy we shouldn't panic about the millions who missed their second vaccine dose—yetMay 5, 2021Maya Wei-HaasBy Maya Wei-Haasbookmark_bordersharemore_vert
BloombergPfizer CEO Says Lower-Income Countries Didn't Order VaccinesMay 7, 2021Riley GriffinBy Riley Griffinbookmark_bordersharemore_vert
CNBCPfizer plans to file for full FDA approval of Covid vaccine at the end of this monthMay 4, 2021Berkeley Lovelace & Berkeley Lovelace Jr.By Berkeley Lovelace & Berkeley Lovelace Jr.bookmark_bordersharemore_vert
CNBCPfizer CEO opposes U.S. call to waive Covid vaccine patents, cites manufacturing and safety issuesMay 7, 2021Kevin BreuningerBy Kevin Breuningerbookmark_bordersharemore_vert
ReutersBioNTech nearing request for approval of longer-lasting version of COVID vaccineMay 4, 2021Louise Heavens, Ludwig Burger & Alistair SmoutBy Louise Heavens, Ludwig Burger & Alistair Smoutbookmark_bordersharemore_vert
ForbesAstraZeneca And Pfizer Covid-19 Vaccines More Than 86% Effective After First Dose, South Korean Authorities SayMay 5, 2021Siladitya RayBy Siladitya Raybookmark_bordersharemore_vert
Good Morning AmericaCOVID-19 vaccines and kids: What parents should know9 days agoKatie KindelanBy Katie Kindelanbookmark_bordersharemore_vert
FiercePharmaBioNTech, with partner Pfizer, on track to make 3B COVID vaccine doses in 2021, CEO saysMay 4, 2021Noah Higgins-DunnBy Noah Higgins-Dunnbookmark_bordersharemore_vert
The Wall Street JournalNext Generation of Covid-19 Vaccines Could Be Pill or SprayMay 3, 2021Peter Loftus & Gregory ZuckermanBy Peter Loftus & Gregory Zuckermanbookmark_bordersharemore_vert
University of Minnesota Twin CitiesReal-world studies detail high Pfizer COVID vaccine protectionMay 7, 2021bookmark_bordersharemore_vert
BBC.comCovid vaccine: Biden aims to expand vaccines for adults and childrenMay 5, 2021bookmark_bordersharemore_vert
The New York TimesPfizer-BioNTech Vaccine is Highly Effective Against Variants, Studies Find (Published 2021)May 7, 2021Emily AnthesBy Emily Anthesbookmark_bordersharemore_vert
The TelegraphHow the Moderna, AstraZeneca, Pfizer and other Covid vaccines compareMay 28, 2021Annelies Gartner, Anne Gulland & Jennifer RigbyBy Annelies Gartner, Anne Gulland & Jennifer Rigbybookmark_bordersharemore_vert
CNNPfizer to seek authorization for Covid-19 vaccine for children ages 2 to 11 in SeptemberMay 4, 2021Naomi ThomasBy Naomi Thomasbookmark_bordersharemore_vert
Health EssentialsWhy It's Important to Get Your Second COVID-19 Vaccine DoseMay 3, 2021bookmark_bordersharemore_vert
NPRPfizer Seeks Full FDA Approval For COVID-19 VaccineMay 7, 2021Emma BowmanBy Emma Bowmanbookmark_bordersharemore_vert
NBC NewsFDA preparing to authorize Pfizer Covid vaccine for 12- to 15-year-olds as early as next weekMay 4, 2021Lauren Egan & Laura StricklerBy Lauren Egan & Laura Stricklerbookmark_bordersharemore_vert
BBC.comCovid: Canada authorises Pfizer vaccine for children aged 12 to 15May 5, 2021Rachel SchraerBy Rachel Schraerbookmark_bordersharemore_vert
Reuters IndiaPfizer says it told India there no safety concern with its COVID-19 vaccineMay 3, 2021Krishna N. DasBy Krishna N. Dasbookmark_bordersharemore_vert
Reuters CanadaCanada allows Pfizer COVID-19 vaccine for children aged 12-15May 5, 2021David LjunggrenBy David Ljunggrenbookmark_bordersharemore_vert
ReutersPfizer sees robust COVID-19 vaccine demand for years, $26 bln in 2021 salesMay 4, 2021Michael Erman & Manas MishraBy Michael Erman & Manas Mishrabookmark_bordersharemore_vert
BloombergPfizer (PFE) Boosts Forecast for Covid-19 Shot Sales as Profits JumpMay 4, 2021Riley GriffinBy Riley Griffinbookmark_bordersharemore_vert
CNBCPfizer and BioNTech begin the process of seeking full U.S. approval for their Covid vaccineMay 7, 2021Berkeley Lovelace, Berkeley Lovelace Jr. & Dawn KopeckiBy Berkeley Lovelace, Berkeley Lovelace Jr. & Dawn Kopeckibookmark_bordersharemore_vert
The New York TimesCovid-19: F.D.A. to Authorize Pfizer Vaccine for Adolescents by Early Next Week (Published 2021)May 14, 2021Apoorva Mandavilli, Kate Taylor & Will WrightBy Apoorva Mandavilli, Kate Taylor & Will Wrightbookmark_bordersharemore_vert
The New York TimesPfizer Reaps Hundreds of Millions in Profits From Covid Vaccine (Published 2021)May 5, 2021Rebecca Robbins & Peter S. GoodmanBy Rebecca Robbins & Peter S. Goodmanbookmark_bordersharemore_vert